Print this page    •   Back to Web version of article

Bottom Line on the Three New Drugs

October 2003

Enfuvirtide (T-20, Fuzeon)

Atazanavir (Reyataz)

Emtricitabine (FTC, Emtriva)

Back to the Project Inform Perspective October 2003 contents page.

This article was provided by Project Inform. It is a part of the publication Project Inform Perspective. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.